Parameter
| Biomarker | NCR3LG1 | Full name | Natural Cytotoxicity Receptor 3 Ligand 1 | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Prognosis |
| Disease | Bladder Cancer (BC) | Disease Subtypes | / | ||
| Organ | Bladder | Test Sample / Technology Platform | Tissue & cells (expression intervention) | ||
| Pathobiological Mechanisms | Participates in BC progression; potential prognostic biomarker | ||||
| Clinical Availability Status | Research verification stage | ||||
| Notes and Dynamics | Novel immune-related marker; preliminary cellular & tissue evidence; clinical validation | ||||